Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1996
02/08/1996WO1996003396A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
02/08/1996WO1996003394A1 Semi-synthetic taxanes with anti-tumoural activity
02/08/1996WO1996003393A1 Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
02/08/1996WO1996003392A1 Substituted thiazoles for the treatment of inflammation
02/08/1996WO1996003388A1 1,2-substituted imidazolyl compounds for the treatment of inflammation
02/08/1996WO1996003385A1 3,4-substituted pyrazoles for the treatment of inflammation
02/08/1996WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS
02/08/1996WO1996003382A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
02/08/1996WO1996003381A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof
02/08/1996WO1996003380A1 Aromatic amino ethers as pain relieving agents
02/08/1996WO1996003377A1 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
02/08/1996WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS
02/08/1996WO1996003374A1 Thrombin inhibitors
02/08/1996WO1996003371A1 N-acyl-n-(substituted cinnamoyl)ethylenediamine derivative
02/08/1996WO1996003152A1 Antisense oligonucleotides against hepatitis b viral replication
02/08/1996WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
02/08/1996WO1996003150A1 Compositions containing hemicelluloses and polyphenols for treating gastrointestinal disorders
02/08/1996WO1996003149A1 Antifungal-wound healing compositions and methods for preparing and using same
02/08/1996WO1996003148A1 Method and drug for treating diabetes
02/08/1996WO1996003139A1 Use of nitric oxide or nitric oxide adducts to preserve platelets
02/08/1996WO1996003136A1 Inhibition of platelet binding
02/08/1996WO1996003135A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients
02/08/1996WO1996003134A1 Treatment of diarrhea with 2-substituted adenosine derivatives
02/08/1996WO1996003132A1 Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide
02/08/1996WO1996003131A1 Percutaneously absorbable preparation
02/08/1996WO1996003130A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
02/08/1996WO1996003129A1 Method of treating sweat-related conditions
02/08/1996WO1996003128A1 Preparation of fusidic acid tablets
02/08/1996WO1996003127A1 A method of treating chemical dependency in mammals and a composition therefor
02/08/1996WO1996003126A1 Method of treating opportunistic infections with azaspiranes
02/08/1996WO1996003125A1 Carbon monoxide dependent guanylyl cyclase modifiers
02/08/1996WO1996003123A1 Methods
02/08/1996WO1996003122A2 Use of gabapentin in the treatment of anxiety and panic
02/08/1996WO1996003121A1 Antiphlogistic, analgesic, antipyretic injection preparation
02/08/1996WO1996003120A1 INDENE sPLA2 INHIBITORS
02/08/1996WO1996003119A1 Transdermal delivery device containing an estrogen
02/08/1996WO1996003113A1 Self-emulsifying drug delivery system
02/08/1996WO1996003110A1 Lipophilic hydroxylated acid, cosmetic and pharmaceutical use thereof and method for preparing same
02/08/1996WO1995022611A3 Methods and compositions for stimulating bone cells
02/08/1996DE4428835A1 Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 3-substituted 3H-2,3-benzodiazepine derivatives, their preparation and use as medicaments
02/08/1996DE4427648A1 N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung N-Stubstituierte 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
02/08/1996DE4427647A1 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung N-substituted Azabicycloheptan derivatives, their preparation and use
02/08/1996DE4427530A1 New 7-tri:cyclic amino-quinolone or naphthyridone derivs
02/08/1996CA2196091A1 D-mannose or xylitol esters and their use as drugs
02/08/1996CA2196078A1 Imidazopyridine-azolidinones
02/08/1996CA2196077A1 Benzyl-imidazopyridines
02/08/1996CA2196076A1 Acyl imidazopyridines
02/08/1996CA2196075A1 Halogenated imidazopyridines
02/08/1996CA2196070A1 Antisense oligonucleotides against hepatitis b viral replication
02/08/1996CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
02/08/1996CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy
02/08/1996CA2196046A1 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
02/08/1996CA2195847A1 Substituted thiazoles for the treatment of inflammation
02/08/1996CA2195845A1 1,2-substituted imidazolyl compounds for the treatment of inflammation
02/08/1996CA2195778A1 Method of treating opportunistic infections with azaspiranes
02/08/1996CA2195748A1 Percutaneously absorbable preparation
02/08/1996CA2195647A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof
02/08/1996CA2195646A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof
02/08/1996CA2195630A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof
02/08/1996CA2195623A1 Self-emulsifying drug delivery system
02/08/1996CA2195570A1 Indolizine spla2 inhibitors
02/08/1996CA2195569A1 1h-indole-1-functional spla2 inhibitors
02/08/1996CA2195432A1 Indene spla2 inhibitors
02/08/1996CA2195420A1 Compounds useful as antiproliferative agents and garft inhibitors
02/08/1996CA2195417A1 Compounds useful as antiproliferative agents and garft inhibitors
02/08/1996CA2195302A1 Carbon monoxide dependent guanylyl cyclase modifiers
02/08/1996CA2195123A1 3,4-substituted pyrazoles for the treatment of inflammation
02/08/1996CA2193852A1 Method of treating sweat-related conditions
02/08/1996CA2193844A1 Thrombin inhibitors
02/08/1996CA2192789A1 Tetracyclic triterpenes
02/08/1996CA2192088A1 Aromatic amino ethers as pain relieving agents
02/08/1996CA2191603A1 Antifungal-wound healing compositions and methods for preparing and using same
02/08/1996CA2187445A1 Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same
02/07/1996EP0695755A1 Pyrrolocarbazoles
02/07/1996EP0695752A1 New anthraquinonic derivatives having an antitumor activity, and applications thereof
02/07/1996EP0695751A1 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it
02/07/1996EP0695747A1 Derivatives of substituted N-oxide 1-(7-chloroquinolin-4-yl)pyrozole-3-carboxamides as ligand of the neurotensin receptor
02/07/1996EP0695551A2 Laxative composition containing a bulk laxative and a lubricating laxatif
02/07/1996EP0695550A2 Product for strengthening the human body, containing parsnip contituents and vitamins
02/07/1996EP0695549A1 Use of polydeoxyribonucleotides in diabetic neuropathies
02/07/1996EP0695548A1 A stably storable and readily water soluble composition of cephalosporin for injections
02/07/1996EP0695546A1 Powders based on metoclopramide and paracetamol or acetylsalicylic acid derivatives
02/07/1996EP0695545A1 Use of diphenylethane derivatives for the treatment of glaucoma
02/07/1996EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours
02/07/1996EP0695305A1 Method of forming oligonucleotides
02/07/1996EP0695303A1 New pyridinium salts and their use for controlling helicobacter bacteria
02/07/1996EP0695300A1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
02/07/1996EP0695297A1 1,5-benzodiazepines useful as gastrin or cck-antagonists
02/07/1996EP0695294A1 Michellamines useful as antiviral agents
02/07/1996EP0695293A1 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
02/07/1996EP0695187A1 Compositions for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
02/07/1996EP0695185A1 New method of treatment
02/07/1996EP0695183A1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
02/07/1996EP0695182A1 Systems for controlled release of pilocarpine
02/07/1996EP0695181A1 Methods of using hesperetin for sebum control and treatment of acne
02/07/1996EP0695180A1 Novel medical use for gaba agonists
02/07/1996EP0695179A1 Transdermal antiinflammatory composition
02/07/1996EP0695178A1 Management of cholelithiasis with beta-2-agonists
02/07/1996EP0695177A1 Active substance-containing plaster
02/07/1996EP0695176A1 Solid form of administration of isosorbide 5-mononitrate
1 ... 6945 6946 6947 6948 6949 6950 6951 6952 6953 6954 6955 6956 6957 6958 6959 6960 6961 6962 6963 6964 6965 ... 7860